Out of 381 AML patients who met our criteria, 31 had IDH2 mutations, including 23 with R140 (74%) and 8 with R172 (26%), and 8 had IDH1 mutations (all R132). The gene discussed is IDH1; the disease is acute myeloid leukemia.